Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × apixaban × 90 days × Clear all

Sponsor

Conditions

Venous Thromboembolism 4 Pulmonary Embolism 2 Neoplasms 2 Venous Thrombosis 1 Urinary Bladder Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Embolism 1

Interventions

ruxolitinib 5 bomedemstat 2 Specimen Handling 2 Biopsy 2 venetoclax 1 veliparib 1 piperine 1 pevonedistat 1 iadademstat 1 fedratinib 1 demethoxycurcumin 1 decitabine and cedazuridine drug combination 1 Valganciclovir 1 Topotecan 1 Therapeutics 1 Polymerase Chain Reaction 1 Injections 1 INCB057643 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Decitabine 1 Curcumin 1 Carboplatin 1 Azacitidine 1 Antiviral Agents 1 Acetylcysteine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡